Nike's stock (NKE) fell 2.3% to $38.22 on November 3, 2026, giving back part of a 12.8% one-month rally that has lifted it above its 50-day average but not its 40-week average. The balance of evidence leans negative, with low conviction at 1 of 4. The chart shows an overbought bounce inside a weekly downtrend, while relative strength points the other way.
Why it matters
Nothing in the news explains today's drop. The items that mention Nike are about tokenized trading. Nike was among a dozen companies, including Nvidia and Costco, that objected to their shares being traded on the planned ICE/OKX venue, Decrypt reported. That is a legal and market-structure story with no bearing on sales or margins, so it does not explain the move in either direction. The recent rally has a more plausible source in the footwear group. Crocs jumped about 25% after beating earnings and raising its full-year guidance, CNBC reported, and Adidas posted a 19% rise in running revenue, according to Reuters. Those results helped sentiment toward the group but say little about Nike's own recovery.
Over five days NKE rose 1.7%, XLY (the consumer discretionary sector fund) rose 1.5%, and the S&P 500 (SPY) fell 2.1%. Against the sector the stock added only 0.2 points, so the week's gain was almost entirely the sector's. Today the stock fell 2.3% against 0.8% for XLY while SPY edged up 0.2%, so the pullback was larger than the sector's. It came on volume 54.5% below the 20-day average, which makes it a quiet move, not a decisive one. The stock is 2.3% below its November 2 close of $39.12, the recent peak.
The debate over Nike is about whether the turnaround is far enough along to justify the price. The cautious side points to fiscal first-quarter sales that fell 5% on a currency-adjusted basis, and to weak guidance for fiscal 2027, as the Motley Fool noted. A Seeking Alpha author objects to a price-to-earnings multiple above 21 on earnings he expects to stagnate. The constructive side stresses durability: 24 straight years of dividend increases and a yield of 4.3%, with the stock down 77% over five years, as The Motley Fool describes the turnaround. Neither side claims sales are recovering yet.
Valuation sits between those camps. Of 37 analysts, the consensus rating is hold, with a mean price target of $36.50, so the stock trades 4.7% above it. The targets range from $19 to $60, which shows how little agreement there is on where earnings settle. After a 12.8% monthly gain, the stock is no longer priced at the lows.
What the evidence says
The long-term thesis is weakened, and the stock is in a downtrend phase. It trades below its 40-week average and 43.6% below its 52-week high of $67.78, and it is down 40.0% this year while SPY is up 10.5%. Against SPY, the stock is 20.1% behind over 200 days. The 200-day average at $45.79 sits well above the price, so the longer trend has not turned. The recent bounce is a rally inside that downtrend, not a reversal.
For the next two to six weeks the balance of evidence leans negative, and conviction is low at 1 of 4. The main reason is that a rally inside a weekly downtrend has reached overbought, with the 14-day RSI at 66. The price is also approaching $40, a round number where sellers have shown up on earlier rallies. The two relative-strength signals work against that reading. Over 50 days NKE leads SPY by 5.5 points and XLY by 0.2 points, which is the opposite of what a weak stock normally shows. That is why only one of four conviction points is met.
The strongest case against the lean is that the stock is above both its 50-day average ($36.86) and its 10-week average, up 12.8% in a month, and beating the market in a sector that is rising. If buyers keep that momentum and take out $40 and then $41.34, the bounce would extend further than the bearish reading allows. The 50-day lead over XLY is thin, however, and the week's gain was nearly all sector. The light volume on the pullback also fits a pause in a bounce more than a change of trend, so the balance tilts negative but not firmly.
Levels that matter
In a downtrend the structure is defined from above. The stock holds below $40.00, a round number where sellers have appeared on rallies, with $41.34 (a swing zone) just above it. The trend would end only above $45.79, the 200-day average, with $45.00 as a round-number step on the way. Below the price, the 50-day average at $36.86 is the first support, followed by $35.00, the 52-week low of $33.87 and $30.00.
The breakout level is a daily close below $36.86, the 50-day average. From there the target is the 52-week low at $33.87, and the level that would show the move failed is $40.27, which is $40.00 plus a quarter of the 14-day ATR of $1.08. That gives a reward-to-risk of 0.9 to 1, well short of the 3 to 1 that makes a breakout worth the risk. A path to the $30.00 round number would help the arithmetic, as would a much tighter stop. Neither is on the map today, so the downside math is thin even if the direction proves right.
What would change the picture
The rule is a weekly close above $45.79, the 200-day average. That would put the stock back above the line that has capped it and would end the downtrend. A price move alone is not enough to make that durable. The non-price fact that would do it is evidence that sales have stopped shrinking, meaning a return to revenue growth after a 5% currency-adjusted decline in the fiscal first quarter. Until then, rallies toward $40 are testing sellers rather than confirming a recovery.
What to watch
- Earnings, December 17, 2026: the number that matters is the change in revenue, specifically whether the year-over-year decline narrows from the 5% of the last quarter.
- Sector events: footwear peers are moving the stock before its own news. Crocs' guidance raise and Adidas' 19% running growth show competitors gaining, and further peer results and XLY's direction will set the tone.
- Valuation against consensus: at $38.22 the stock is 4.7% above the $36.50 mean target, inside a $19 to $60 range, so the price assumes more improvement than the average analyst does.